Abrocitinib tablets are a Class 1 innovative drug declared by Pfizer, a Janus kinase (JAK) inhibitor. When using abrocitinib tablets for treatment, the following important precautions need special attention:
If a dose is missed, administer it as soon as possible unless it is less than 12 hours until the next dose, in which case the missed dose should be skipped. Thereafter, resume administration at the specified time.
Take abrocitinib tablets at approximately the same time each day, with or without food.
Abrocitinib tablets should be swallowed whole with water. Do not crush, divide, or chew the tablets.

